Last updated on August 2019

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata


Brief description of study

The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).

Clinical Study Identifier: NCT03899259

Find a site near you

Start Over

Investigate MD, LLC

Scottsdale, AZ United States
  Connect »

Quest Dermatology Research

Northridge, CA United States
  Connect »

Kaiser Permanente Hospital

San Francisco, CA United States
  Connect »

New England Research Associates

Bridgeport, CT United States
  Connect »

Dawes Fretzin Clinical Research

Indianapolis, IN United States
  Connect »

The South Bend Clinic

South Bend, IN United States
  Connect »

Forefront Clinical Research

Louisville, KY United States
  Connect »

Qualmedica Research LLC

Owensboro, KY United States
  Connect »

Tufts Medical Center

Boston, MA United States
  Connect »

Hamzavi Dermatology

Fort Gratiot, MI United States
  Connect »

Wake Research Associates

Raleigh, NC United States
  Connect »

Omega Medical Research

Warwick, RI United States
  Connect »

Progressive Clinical Research

San Antonio, TX United States
  Connect »

Virginia Clinical Research

Norfolk, VA United States
  Connect »

Stat Research

Ciudad Autonoma De Buenos Air, Argentina
  Connect »

Centro Medico Privado de Reumatologia

San Miguel de Tucuman, Argentina
  Connect »

Fundacion Respirar

Buenos Aires, Argentina
  Connect »

Buenos Aires Skin

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Instituto de Neumonolog a y Dermatolog a

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Dankook University Hospital

Cheonan, Korea, Republic of
  Connect »

Ajou University Hospital

Suwon, Korea, Republic of
  Connect »